Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Details

Connection

Frank Scott to Biosimilar Pharmaceuticals

This is a "connection" page, showing publications Frank Scott has written about Biosimilar Pharmaceuticals.

 
Connection Strength
  
 
 
0.682
  
  1. Scott FI. Infliximab Versus Biosimilars for IBD: Is It Better to Fight Than Switch? Dig Dis Sci. 2020 08; 65(8):2158-2160.
    View in: PubMed
    Score: 0.682
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)